España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
iRhythm Technologies
IRTC
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$90.39
2.73
3.11%
At close: -
$90.39
0.00050
0.00%
After Hours: Dec 20, 4:01 PM EDT
Get Report
Comment
iRhythm Technologies (IRTC) Forecast
News
Earnings
iRhythm Technologies (IRTC) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for iRhythm Technologies (NASDAQ:IRTC) Stock
iRhythm Technologies Stock (NASDAQ: IRTC)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Wednesday, December 18, 2024
Truist Securities Maintains Buy on iRhythm Te...
Benzinga Newsdesk
Monday, December 09, 2024
Canaccord Genuity Maintains Buy on iRhythm Te...
Benzinga Newsdesk
Tuesday, December 03, 2024
Critical Insights From iRhythm Technologies Analyst Ratings: What You Need To Know
Benzinga Insights
Monday, December 02, 2024
Morgan Stanley Maintains Positive MedTech Outlook Despite Setbacks in 2024, Upgrades Intuitive Surgical And Stryker, Downgrades Nevro And Glaukos
Vandana Singh
Friday, November 01, 2024
iRhythm Technologies shares are trading highe...
Benzinga Newsdesk
Baird Maintains Outperform on iRhythm Technol...
Benzinga Newsdesk
Thursday, October 31, 2024
Forecasting The Future: 6 Analyst Projections For iRhythm Technologies
Benzinga Insights
iRhythm Technologies shares are trading lower...
Benzinga Newsdesk
Needham Maintains Buy on iRhythm Technologies...
Benzinga Newsdesk
Wednesday, October 30, 2024
iRhythm Technologies Receives FDA 510(k) Clea...
Benzinga Newsdesk
iRhythm Sees FY24 Revenue $582.5M-$587.5M Vs ...
Benzinga Newsdesk
iRhythm Technologies Q3 2024 Adj EPS $(1.26) ...
Benzinga Newsdesk
Tuesday, October 29, 2024
Earnings Preview For iRhythm Technologies
Benzinga Insights
Monday, October 28, 2024
iRhythm Technologies Study Shows 14-Day Monit...
Benzinga Newsdesk
Sunday, October 27, 2024
Trump Media & Tech, ImmunityBio, And iRhythm Are Among Top 10 Mid Cap Gainers Last Week (Oct 21-Oct 25): Are The Others In Your Portfolio?
Lekha Gupta
Tuesday, October 22, 2024
Nasdaq Turns Higher; Verizon Shares Fall After Q3 Results
Avi Kapoor
Truist Securities Maintains Buy on iRhythm Te...
Benzinga Newsdesk
With FDA Approval iRhythm May Be Able To Lift Regulatory Overhang, Investor Skepticism, Analyst Says
Vandana Singh
Crude Oil Rises Sharply; 3M Posts Upbeat Earnings
Avi Kapoor
Quest Diagnostics Posts Upbeat Results, Joins GM, Philip Morris And Other Big Stocks Moving Higher On Tuesday
Avi Kapoor
Market-Moving News for October 22nd
Benzinga Newsdesk
iRhythm Technologies shares are trading highe...
Benzinga Newsdesk
Why iRhythm Technologies Shares Are Trading Higher By Over 20%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
Monday, October 21, 2024
12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga Insights
iRhythm Technologies shares are trading highe...
Benzinga Newsdesk
iRhythm Technologies Secures FDA 510(k) Clear...
Benzinga Newsdesk
Monday, October 14, 2024
Beyond The Numbers: 9 Analysts Discuss iRhythm Technologies Stock
Benzinga Insights
Truist Securities Maintains Buy on iRhythm Te...
Benzinga Newsdesk
Friday, October 04, 2024
iRhythm Technologies shares are trading lower...
Benzinga Newsdesk
Goldman Sachs Initiates Coverage On iRhythm T...
Benzinga Newsdesk
Wednesday, September 25, 2024
Key Takeaways From iRhythm Technologies Analyst Ratings
Benzinga Insights
Canaccord Genuity Maintains Buy on iRhythm Te...
Benzinga Newsdesk
Wednesday, September 11, 2024
iRhythm Technologies Announces Approval From ...
Benzinga Newsdesk
Wednesday, September 04, 2024
iRhythm Teams Up With BioIntelliSense, Expand...
Benzinga Newsdesk
Tuesday, September 03, 2024
Reported Earlier, iRhythm's GUARD-AF Trial Hi...
Benzinga Newsdesk
Thursday, August 29, 2024
Build-A-Bear Workshop Posts Upbeat Earnings, Joins Affirm, Nutanix, Cooper Companies, Veeva Systems And Other Big Stocks Moving Higher On Thursday
Avi Kapoor
Thursday, August 22, 2024
Expert Ratings For iRhythm Technologies
Benzinga Insights
Citigroup Maintains Buy on iRhythm Technologi...
Benzinga Newsdesk
Friday, August 02, 2024
JP Morgan Maintains Overweight on iRhythm Tec...
Benzinga Newsdesk
iRhythm Technologies shares are trading lower...
Benzinga Newsdesk
Oppenheimer Maintains Outperform on iRhythm T...
Benzinga Newsdesk
Baird Maintains Outperform on iRhythm Technol...
Benzinga Newsdesk
Truist Securities Reiterates Buy on iRhythm T...
Benzinga Newsdesk
4 Analysts Assess iRhythm Technologies: What You Need To Know
Benzinga Insights
Needham Maintains Buy on iRhythm Technologies...
Benzinga Newsdesk
Thursday, August 01, 2024
iRhythm Technologies Announces Brice Bobzien,...
Benzinga Newsdesk
iRhythm shares are trading lower following Q2...
Benzinga Newsdesk
iRhythm Sees FY24 Revenue ~580M-$590M Vs $583...
Benzinga Newsdesk
iRhythm Technologies Q2 2024 Adj. EPS $(0.61)...
Benzinga Newsdesk
Tuesday, July 16, 2024
The Analyst Verdict: iRhythm Technologies In The Eyes Of 5 Experts
Benzinga Insights
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch